Studies on CD27 and CD70 expression levels on bulk TILs administered to melanoma patients after chemotherapy indicated that CD27+CD8+and CD70+CD8+TIL pools were significantly higher (p = 0.004 and p = 0.01, respectively) in responders and associated with tumor regression following adoptive cell transfer [166]. This evidence concerns the gene CD8A and neoplasm.